Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Sales increase 14% for pharmaceutical company
June 6th, 2005
At the annual meeting of Abbott shareholders, chairman and CEO Miles D. White highlighted the company's strong performance across both its Pharmaceutical Products Group and Medical Products Group in 2004, a direct result of executing on the strategy to reshape the company, giving Abbott a refined focus on high-growth, innovation-driven businesses. "Abbott's performance was outstanding in 2004," said White. "Overall sales increased 14%, and both of our operating groups delivered double-digit growth. Our medical products business had its best performance in a decade. And our U.S. pharmaceutical business was the second-fastest growing among our peers for the second...
Source: Biotech Business Week (2005-06-06)
|
